91 related articles for article (PubMed ID: 1899696)
1. Biological significance of tissue plasminogen activator content in brain tumors.
Sawaya R; Rämö OJ; Shi ML; Mandybur G
J Neurosurg; 1991 Mar; 74(3):480-6. PubMed ID: 1899696
[TBL] [Abstract][Full Text] [Related]
2. [A plasminogen regulation system in brain tumors].
Kit OI; Frantsiyants EM; Kozlova LS; Rostorguev EE; Balyazin-Parfenov IV; Pogorelova YA
Zh Vopr Neirokhir Im N N Burdenko; 2017; 81(2):22-27. PubMed ID: 28524122
[TBL] [Abstract][Full Text] [Related]
3. Tissue plasminogen activator expression in meningiomas and glioblastomas.
Goh KY; Poon WS; Chan DT; Ip CP
Clin Neurol Neurosurg; 2005 Jun; 107(4):296-300. PubMed ID: 15885387
[TBL] [Abstract][Full Text] [Related]
4. Plasminogen activator inhibitor-1 in brain tumors: relation to malignancy and necrosis.
Sawaya R; Yamamoto M; Rämö OJ; Shi ML; Rayford A; Rao JS
Neurosurgery; 1995 Feb; 36(2):375-80; discussion 380-1. PubMed ID: 7731519
[TBL] [Abstract][Full Text] [Related]
5. Urokinase plasminogen activator is elevated in human astrocytic gliomas relative to normal adjacent brain.
Kinder DH; Berger MS; Mueller BA; Silber JR
Oncol Res; 1993; 5(10-11):409-14. PubMed ID: 8054701
[TBL] [Abstract][Full Text] [Related]
6. Correlation of tumor plasminogen activator with peritumoral cerebral edema. A CT and biochemical study.
Quindlen EA; Bucher AP
J Neurosurg; 1987 May; 66(5):729-33. PubMed ID: 3106592
[TBL] [Abstract][Full Text] [Related]
7. Prognostic significance of proteolytic enzymes in human brain tumors.
Bindal AK; Hammoud M; Shi WM; Wu SZ; Sawaya R; Rao JS
J Neurooncol; 1994; 22(2):101-10. PubMed ID: 7538161
[TBL] [Abstract][Full Text] [Related]
8. Measurement of plasminogen activator system components in plasma and tumor tissue extracts obtained from patients with breast cancer: an EORTC Receptor and Biomarker Group collaboration.
Grebenchtchikov N; Maguire TM; Riisbro R; Geurts-Moespot A; O'Donovan N; Schmitt M; McGreal G; McDermott E; O'Higgins N; Brünner N; Sweep CG; Duffy MJ
Oncol Rep; 2005 Jul; 14(1):235-9. PubMed ID: 15944795
[TBL] [Abstract][Full Text] [Related]
9. Immunohistochemical demonstration of alpha-1-proteinase inhibitor in brain tumors.
Zuccarello M; Sawaya R; Ray MB
Cancer; 1987 Aug; 60(4):804-9. PubMed ID: 3297299
[TBL] [Abstract][Full Text] [Related]
10. Immunohistochemical localization of plasminogen activator inhibitor type 1 in human brain tumors.
Kono S; Rao JS; Bruner JM; Sawaya R
J Neuropathol Exp Neurol; 1994 May; 53(3):256-62. PubMed ID: 8176408
[TBL] [Abstract][Full Text] [Related]
11. Quantitative apparent diffusion coefficients in the characterization of brain tumors and associated peritumoral edema.
Server A; Kulle B; Maehlen J; Josefsen R; Schellhorn T; Kumar T; Langberg CW; Nakstad PH
Acta Radiol; 2009 Jul; 50(6):682-9. PubMed ID: 19449234
[TBL] [Abstract][Full Text] [Related]
12. Plasminogen activators and inhibitors in gliomas: an immunohistochemical study.
Caccamo DV; Keohane ME; McKeever PE
Mod Pathol; 1994 Jan; 7(1):99-104. PubMed ID: 8159659
[TBL] [Abstract][Full Text] [Related]
13. Plasminogen activator activity and molecular weight patterns in human brain tumors.
Sawaya R; Highsmith R
J Neurosurg; 1988 Jan; 68(1):73-9. PubMed ID: 3335914
[TBL] [Abstract][Full Text] [Related]
14. Elevated levels of urokinase-type plasminogen activator and plasminogen activator inhibitor type-1 in malignant human brain tumors.
Landau BJ; Kwaan HC; Verrusio EN; Brem SS
Cancer Res; 1994 Feb; 54(4):1105-8. PubMed ID: 8313368
[TBL] [Abstract][Full Text] [Related]
15. Diffusion tensor imaging provides an insight into the microstructure of meningiomas, high-grade gliomas, and peritumoral edema.
De Belder FE; Oot AR; Van Hecke W; Venstermans C; Menovsky T; Van Marck V; Van Goethem J; Van den Hauwe L; Vandekerckhove M; Parizel PM
J Comput Assist Tomogr; 2012; 36(5):577-82. PubMed ID: 22992609
[TBL] [Abstract][Full Text] [Related]
16. Tissue plasminogen activator and urokinase plasminogen activator in human epileptogenic pathologies.
Iyer AM; Zurolo E; Boer K; Baayen JC; Giangaspero F; Arcella A; Di Gennaro GC; Esposito V; Spliet WG; van Rijen PC; Troost D; Gorter JA; Aronica E
Neuroscience; 2010 May; 167(3):929-45. PubMed ID: 20219643
[TBL] [Abstract][Full Text] [Related]
17. Factors responsible for the retention of fluid in human tumor edema and the effect of dexamethasone.
Bodsch W; Rommel T; Ophoff BG; Menzel J
J Neurosurg; 1987 Aug; 67(2):250-7. PubMed ID: 3598684
[TBL] [Abstract][Full Text] [Related]
18. Peritumoral brain regions in gliomas and meningiomas: investigation with isotropic diffusion-weighted MR imaging and diffusion-tensor MR imaging.
Provenzale JM; McGraw P; Mhatre P; Guo AC; Delong D
Radiology; 2004 Aug; 232(2):451-60. PubMed ID: 15215555
[TBL] [Abstract][Full Text] [Related]
19. Expression and significance of urokinase type plasminogen activator gene in human brain gliomas.
Zhang X; Fei Z; Bu X; Zhen H; Zhang Z; Gu J; Chen Y
J Surg Oncol; 2000 Jun; 74(2):90-4. PubMed ID: 10914816
[TBL] [Abstract][Full Text] [Related]
20. Clinical value of components of the plasminogen activation system in ovarian cyst fluid.
Boss EA; Massuger LF; Thomas CM; Geurts-Moespot A; van Schaik JH; Boonstra H; Sweep CG
Anticancer Res; 2002; 22(1A):275-82. PubMed ID: 12017303
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
